For 20-plus years, Mark Withers had inexplicable episodes of a severe anaphylaxis-like phenomenon. ARUP’s unique expertise and highly sensitive tests help patients like him find the right diagnosis.


As respiratory viruses cocirculate this season, laboratory testing is increasingly essential to inform treatment of children, older adults, and other vulnerable populations.


ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated educational resources for multiple sclerosis, minimal residual disease, and mumps virus.


A new ARUP Consult tool helps clarify the testing requirements for medication management when clinicians are treating patients with multiple sclerosis.


ARUP Consult, a free source of expert guidance in laboratory testing, has updated educational resources for venous thromboembolism, cytomegalovirus, and hemoglobinopathies.


Routine monitoring of patients taking direct factor Xa inhibitors is not required, but the efficacy and safety of this treatment can be measured with ARUP’s newest test offerings.


ARUP CMOs are coauthors of a newly published JAMA Research Letter that summarizes how clinical labs are leading the way in eliminating inequality in healthcare.


ARUP’S new test is the first of its kind to use two distinct biomarkers to identify in utero exposure to kratom, an herbal supplement that may cause neonatal abstinence syndrome.


ARUP Consult provides up-to-date guidance on test selection for the evaluation of liver function, myeloproliferative neoplasms, and hemolytic anemias.


In September, ARUP Consult, a free informative resource in laboratory testing, released new user experience (UX) upgrades and updated several topics, including acute lymphoblastic leukemia.

Subscribe to Test Information